The Georgia Bioscience Commercialization Center has developed a faculty of experienced bioscience executives to offer advice and guidance to start-up firms in Georgia free-of-charge. The GBCC will help guide entrepreneurs to appropriate experts and resources in Georgia.
GBCC Faculty
Ellen Bailey
Director, Midtown Consulting Group
Tom Callaway, MD
Founder, Georgia Venture Partners
Gareth Clarke
Consultant
Rob Derricotte
President, Medical Marketing Insights
Kevin Dilly
former Global Marketing Director, Stiefel - a GSK Company
Laurence Downey, MD
VP of Medical Affairs, Arbor Pharmaceuticals
Bill Dracos
Chief Business Improvement Officer & Associate VP of Administration, Emory University
Paul Fitzpatrick
President
PJ Fitzpatrick Executive Advisory Group
Doug Gooding
Altiris Therapeutics
David Hartnett
Metro Atlanta Chamber
Stephen Hill
President, Abbott Products Inc.
Alexander Jacks III
Vice President,Quality Services & Regulatory Affairs
Karen Kaplan
Fleishman Hillard
Walt Addison Linscott
Thompson Hine
Frank McDaniel
McDaniel & Henry
Susan Nicholas
Singrid Investments
Chris Offen
CEO, Wynden Pharmaceuticals LLC
Russell Plumb
President & CEO, Inhibitex, Inc
Ed Schutter
Arbor Pharmaceuticals
Harold Shlevin, PhD.
ATDC, Georgia Institute of Technology
Tom Stribling
Northampton Medical
Bill Taylor
President & Chief Operating Officer
MiMedx Group, Inc.
Tony Tebbutt
Consultant
Eric Tomlinson, DSc, PhD
Altea Therapeutics
Rick Timmer
AIM Therapeutics
Jay Yadav, MD
Chairman and CEO, CardioMEMS, Inc